Tilray Brands, Inc. Deferred Federal Income Tax Expense (Benefit)
Tilray Brands, Inc. (TLRY) reported Deferred Federal Income Tax Expense (Benefit) of -$10.55 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-07-28
- Tilray Brands, Inc. deferred federal income tax expense (benefit) for fiscal 2026 was -$10.55M.
- Tilray Brands, Inc. deferred federal income tax expense (benefit) for fiscal 2025 was -$10.02M.
- Tilray Brands, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was -$723.00K.
- Tilray Brands, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$4.05M, a 879.81% decline from fiscal 2022.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2026-05-31 | -$10.55M 10-K · filed 2026-07-28 | |
| 2025-05-31 | -$10.02M 10-K · filed 2026-07-28 | |
| 2024-05-31 | -$723.00K 10-K · filed 2026-07-28 | |
| 2023-05-31 | -$4.05M 10-K · filed 2025-07-29 | |
| 2022-05-31 | $520.00K 10-K · filed 2024-07-30 | -$17.15M 10-K · filed 2022-07-28 |
| 2021-05-31 | $1.52M 10-K · filed 2023-07-26 | -$30.11M 10-K · filed 2021-07-28 |
| 2020-12-31 | -$4.91M 10-K · filed 2021-02-19 | |
| 2020-05-31 | -$9.23M 10-K · filed 2022-07-28 | |
| 2019-12-31 | -$3.38M 10-K · filed 2021-02-19 | |
| 2019-05-31 | -$3.28M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |